Medicinal atorvastatin calcium composition capsules for treating coronary heart disease

A technology of atorvastatin calcium and composition, applied in the field of medicine, can solve the problems of high water content of sulfobutyl-β-cyclodextrin, degradation of atorvastatin calcium, low bioavailability and the like, and achieve water and impurities. Low content, reduced myalgia side effects, improved solubility

Inactive Publication Date: 2015-11-11
QINGDAO HUAZHICAO PHARMA CO LTD
View PDF8 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] Chinese patent CN102139115B discloses the cyclodextrin inclusion compound of atorvastatin and the preparation method of oral solid preparation thereof, the sulfobutyl-β-cyclodextrin used has high moisture content, which easily leads to the degradation of atorvastatin calcium
[0012] In a word, in th

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicinal atorvastatin calcium composition capsules for treating coronary heart disease
  • Medicinal atorvastatin calcium composition capsules for treating coronary heart disease
  • Medicinal atorvastatin calcium composition capsules for treating coronary heart disease

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0034] Example 1: Preparation of Atorvastatin Calcium Crystal

[0035] Dissolve atorvastatin calcium in a mixed solvent of ethanol and N-methylpyrrolidone whose volume is 10 times the weight of atorvastatin calcium at 35°C. The volume ratio of ethanol and N-methylpyrrolidone is 3:1. After the dissolution is complete, add chloroform solvent with a volume of 8 times the weight of atorvastatin calcium, reduce the temperature to room temperature within 2 hours, keep it at room temperature for 3 hours, and then further reduce the temperature to -5°C, and then- Place it at 5°C for 3 hours to precipitate crystals and obtain atorvastatin calcium crystals.

[0036] The X-ray powder diffraction pattern of the prepared atorvastatin calcium crystal measured by Cu-Kα rays is as follows figure 1 Shown.

Example Embodiment

[0037] Example 2: Preparation of Atorvastatin Calcium Capsules

[0038] Prescription: 1 part by weight of the atorvastatin calcium crystal compound prepared in Example 1, 15 parts by weight of starch, 0.4 parts by weight of hypromellose, 0.25 parts by weight of dioctyl sulfosuccinate sodium, 95% ethanol 3.1 parts by weight, 0.7 parts by weight of talc;

[0039] Preparation:

[0040] (1) Raw and auxiliary material processing: sieving atorvastatin calcium through 100 mesh;

[0041] (2) Weighing: Weigh according to the craft prescription;

[0042] (3) The preparation of the adhesive: take the prescription amount of hypromellose and dioctyl sodium sulfosuccinate and dissolve it in 95% ethanol for use;

[0043] (4) Mixing granulation: Add atorvastatin calcium and starch to the wet mixing granulator, turn on the mixing motor for dry mixing for 10 minutes; add the prepared binder for wet mixing and cutting, and use a 16 mesh sieve to make soft material;

[0044] (5) Drying: add the wet granul...

Example Embodiment

[0048] Example 3: Preparation of Atorvastatin Calcium Capsules

[0049] Prescription: 1 part by weight of the atorvastatin calcium crystal compound prepared in Example 1, 18 parts by weight of starch, 0.5 parts by weight of hypromellose, 0.3 parts by weight of dioctyl sulfosuccinate sodium, 95% ethanol 3.2 parts by weight, 0.8 parts by weight of talc;

[0050] Preparation:

[0051] (1) Raw and auxiliary material processing: sieving atorvastatin calcium through 100 mesh;

[0052] (2) Weighing: Weigh according to the craft prescription;

[0053] (3) The preparation of the adhesive: take the prescription amount of hypromellose and dioctyl sodium sulfosuccinate and dissolve it in 95% ethanol for use;

[0054] (4) Mixing granulation: Add atorvastatin calcium and starch to the wet mixing granulator, turn on the mixing motor for dry mixing for 10 minutes; add the prepared binder for wet mixing and cutting, and use a 16 mesh sieve to make soft material;

[0055] (5) Drying: add the wet granule...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses medicinal atorvastatin calcium composition capsules for treating a coronary heart disease and belongs to the technical field of medicines. The capsules are prepared by atorvastatin calcium, starch, hydroxypropyl methylcellulose, dioctyl sodium sulphosuccinate, 95% of ethyl alcohol and talcum powder. The atorvastatin calcium is a novel crystal form compound, an X-ray powder diffraction diagram obtained through Cu-Ka ray measurement is shown in Figure 1 and is different from the atorvastatin calcium reported in the prior art, a test shows that the novel crystal form compound has obvious improved moisture absorption, solubility of the medicine in an acid medium and water is improved, the moisture and impurity content is low, the stability is good, the atorvastatin calcium is prevented from being destroyed in the acid environment of the stomach, the occurrence rate of the side effect of myalgia is reduced, and the prepared capsules are high in dissolution rate and good in stability.

Description

technical field [0001] The invention belongs to the technical field of medicine and relates to a capsule of atorvastatin calcium composition for treating coronary heart disease. Background technique [0002] Atorvastatin calcium (Atorvastatin Calcium) belongs to the inhibitor of hydroxymethylglutaryl CoA (HMG-CoA) reductase, which can reduce the concentration of cholesterol in plasma and serum lipoprotein by inhibiting the biosynthesis of HMG-COA reductase and cholesterol in the liver. And by increasing the liver low-density lipoprotein receptors on the cell surface to enhance the uptake and metabolism of low-density lipoprotein. Atorvastatin calcium can effectively reduce plasma total cholesterol, low-density lipoprotein cholesterol, apolipoprotein and triglyceride in patients with homozygous and heterozygous familial hypercholesterolemia, nonfamilial cholesterolemia and mixed lipid metabolism disorders At the same time, the levels of high-density lipoprotein cholesterol a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/48A61K31/40C07D207/34A61P9/10A61P3/06A61K47/38
Inventor 刘学键
Owner QINGDAO HUAZHICAO PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap